RV4660C CY0203
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RV4660C CY0203, covering 2025-09-10 to 2025-09-10. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Effect of the Product RV4660C CY0203 on Clinical, Biometrological and Biological Parameters in Adults With Mild to Moderate Atopic Dermatitis, an Exploratory Study